Skip to content

clinical study on shatpushpa taila nasya(nasal drops) in absence of menses .

Effect of Shatpushpa taila Navana nasya in Artavakshaya for varying durations- A randomized controlled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066520
Enrollment
90
Registered
2024-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N915- Oligomenorrhea, unspecified

Interventions

None listed

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a.)Female patients between the age of 18-35 yrs. b.)Amenorrhea beyond 6 weeks c.) Individual who provide informed consent prior to treatment and voluntarily participate in the trial

Exclusion criteria

Exclusion criteria: a.)Pregnancy b.)Lactating mother c.)Primary amenorrhea d.)Chronic systemic illness e.)Premature menopause f.)Contraindication of navan nasya(navana nasya)

Design outcomes

Primary

MeasureTime frame
Onset of menstruationTimepoint: 14days

Secondary

MeasureTime frame
Compare effect of Navan Nasya given for 3 days, 5 days and 7 daysTimepoint: 14days

Countries

India

Contacts

Public ContactProf Dr Sujata Kadam

All India Institute of Ayurveda

sujatadkadam@gmail.com9890305370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026